Loading...
Proteasome subunit beta type-4 Polyclonal Antibody

42251

Proteasome subunit beta type-4 Polyclonal Antibody

Proteasome subunit beta type-4 Polyclonal Antibody (catalogue number 42251) is a rabbit-derived primary antibody validated for WB IHC, reactive with Human samples. It targets Proteasome subunit beta type-4 (PSMB4): Non-catalytic component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. Supplied as 100μg at ₪1,590.78; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human
Applications
WB IHC
UniProt ID
P28070
Gene
PSMB4
Target organism
Homo sapiens
Catalogue number
42251
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Proteasome subunit beta type-4 (PSMB4) · Homo sapiens

Non-catalytic component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins.

Subcellular location: Cytoplasm; Nucleus

Sequence length: 264 aa · 29204 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.